Lilian Buch

Senior Director, Market Access Strategy at Glaukos Corporation

Speaker

Lilian Buch is Senior Director, Market Access Strategy at Glaukos, setting strategies to optimize access and reimbursement for innovative therapies. Lilian drives market access solutions to ensure access to critical treatments and possesses deep expertise in assessing and determining the implications of key healthcare policies on patients and providers.

Lilian has over 20 years of experience in the pharmaceutical industry with expertise in commercial payer medical policy and utilization management, Medicare payment models, and impact of healthcare policy on patient access. Lilian has specifically focused on creating solutions and removing hurdles to optimize outcomes for patients and providers by supporting and executing access and reimbursement program strategies in oncology, rheumatology, and rare diseases.

Lilian earned a BA in biology from the University of Northern Iowa and is a Certified Professional Biller.